Opioids in the Management of Chronic Non-Cancer Pain: An Update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines

BACKGROUND: Opioid abuse has continued to increase at an alarming rate since our last opioid guidelines were published in 2005. Available evidence suggests a continued wide variance in the use of opioids, as documented by different medic...

AM Trescot，S Helm，H Hansen，... - 《Pain Physician》

Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Mos...

▪ Summary of consensus:1. The use of opioids in cancer pain:  The criteria for selecting analgesics for pain treatment in the elderly include, ...

Joseph，Pergolizzi，Rainer，... - 《Pain Practice》

Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine

Buprenorphine was not used widely in clinical practice over many years, mainly due to analgesic potency and clinical safety concerns based on misinterprete...

HG Kress - 《European Journal of Pain》

Buprenorphine Transdermal Delivery System in Adults with Persistent Noncancer-Related Pain Syndromes Who Require Opioid Therapy: A Multicenter, 5-Week Run-...

Results of this study were presented in part at the annual meeting of the American Pain Society, March 30-April 2, 2005, Boston, Massachusetts.

CJ Landau，WD Carr，AJ Razzetti，... - 《Clinical Therapeutics》

Buprenorphine in long-term control of chronic pain in cancer patients.

The aim of this randomized open-label prospective study was to evaluate the analgesic activity of in a transdermal formulation for control versus sustained...

MC Pace，MB Passavanti，E Grella，... - 《Frontiers in Bioscience A Journal & Virtual Library》

Transdermal buprenorphine – a critical appraisal of its role in pain management

This paper reviews the current clinical data for the role of transdermal buprenorphine (BUP TDS) in the treatment of diverse acute and chronic pain syndrom...

G Hans，D Robert - Dove Medical Press

Allergic contact dermatitis from transdermal buprenorphine

Background: Buprenorphine is a low-molecular-weight, lipophilic, opioid analgesic. The transdermal delivery system (TDS) containing it has skin irritation ...

 - 《Contact Dermatitis》

A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers.

Establishing local tolerability of transdermal opioid systems is important as more systems become available for use in a range of indications. We compared ...

Peter，Schmid-Grendelmeier，Rolf，... - 《Current Medical Research & Opinion》

Clinical Pharmacology of Buprenorphine in relation to its use as an alagesic

Establishing local tolerability of transdermal opioid systems is important as more systems become available for use in a range of indications. We compared ...

Lewis，JW

Benefits and adverse effects of opioids

Establishing local tolerability of transdermal opioid systems is important as more systems become available for use in a range of indications. We compared ...

C Stannard，M Coupe，T. Pickering